Natural Alternatives Posts 26% Revenue Growth In Q4

  • Natural Alternatives International Inc NAII reported fourth-quarter FY21 sales growth of 26.5% year-on-year, to $44.4 million.
  • The private-label contract manufacturing sales rose 21.2% Y/Y. The increase in contract manufacturing sales was driven by higher sales of immune and wellness products.
  • Gross profit climbed 21.4% Y/Y to $7.9 million, with the margin contracting 70 basis points to 17.9%.
  • The operating margin was 7.9%, and operating income for the quarter rose 68.7% to $3.5 million.
  • EPS of $0.47 increased 74% Y/Y.
  • Natural Alternatives held $32.1 million in cash and equivalents as of June 30, 2021.
  • The company expects some challenges related to supply chain and staffing in 1H and the manufacturing challenges to be substantially resolved during 2H of FY22.
  • Outlook: Natural Alternatives sees FY22 sales growth of 5.0% - 10.0% from FY21.
  • Price Action: NAII shares closed lower by 4.76% at $14.20 on Monday.
Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!